1cP-LSD

1cP-LSD
Clinical data
Other names	1-CPA-LSD; 1-cyclopropanoyl-LSD; 1-(Cyclopropylmethanoyl)-LSD; 1cP; Curie
Routes of; administration	Oral
Drug class	Serotonergic psychedelic; Hallucinogen
Legal status
Legal status	AU: S9 (Prohibited substance); BR: Class F2 (Prohibited psychotropics); CA: Unscheduled.; DE: NpSG (Industrial and scientific use only); UK: Under Psychoactive Substances Act;
Pharmacokinetic data
Duration of action	5–10 hours
Identifiers
	IUPAC name (6aR,9R)-N,N-diethyl-7-methyl-4-cyclopropylmethanoyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide;
CAS Number	2767597-50-0;
PubChem CID	155884675;
ChemSpider	107450612;
UNII	7UU7S6TN3J;
Chemical and physical data
Formula	C24H29N3O2
Molar mass	391.515 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCN(CC)C(=O)[C@@H]5C=C2[C@@H](Cc3cn(C(=O)C1CC1)c4cccc2c34)N(C)C5;
	InChI InChI=1S/C24H29N3O2/c1-4-26(5-2)23(28)17-11-19-18-7-6-8-20-22(18)16(12-21(19)25(3)13-17)14-27(20)24(29)15-9-10-15/h6-8,11,14-15,17,21H,4-5,9-10,12-13H2,1-3H3/t17-,21-/m1/s1; Key:RAFUPYYDHPFASC-DYESRHJHSA-N;

1cP-LSD, or 1-CPA-LSD, also known as 1-cyclopropanoyl-LSD or as Curie, is a psychedelic drug of the lysergamide family and an acylated derivative of lysergic acid diethylamide (LSD) which has been sold as a designer drug. It is a prodrug of LSD.